Evaluating the safety and performance of SpineVision's posterior fixation systems for spinal treatment
Official title: Safety and Performance of the SpineVision Posterior Fixation Systems Lumis®, Plus® and Ulis® in Thoracolumbar Spinal Degenerative Pathologies or Degenerative Disc Disease (DDD) Associated Pathologies Treatment - Fixed D3 Study
Run by Spinevision Sas · NCT06342765 · Data updated 2026-11-12
This study is testing how safe and effective three different SpineVision devices are for treating people with spinal problems in their lower back.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 330 (estimated) |
| Sponsor | Spinevision Sas Industry-sponsored |
| Locations | 3 sites (Bayonne and 2 other locations) |
| Status | Recruiting |
| Started | September 22, 2022 |
| Main results expected | May 30, 2028 |
| Study ends | May 30, 2028 |
| Registry record updated | March 18, 2026 |
| Trial ID | NCT06342765 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who have been implanted with the Lumis®, Plus®, or Ulis® posterior fixation systems.
✕Probably not a fit
Patients with contraindications such as trauma, known allergies to the implant materials, or other serious medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the safety and effectiveness of three SpineVision posterior fixation systems—Lumis®, Plus®, and Ulis®—in treating patients with thoracolumbar spinal degenerative conditions. Participants, either already implanted with these systems or scheduled for surgery, will be monitored for up to 24 months post-implantation. Data collected will include pain levels, disability scores, and any adverse events experienced. The study employs a multicentric, non-randomized design to gather comprehensive insights into patient outcomes.
Why it matters
Potential benefit: If successful, this study could enhance treatment protocols for patients suffering from intervertebral disc degeneration by confirming the safety and effectiveness of these fixation systems.
How similar studies have gone: While this study builds on existing knowledge of spinal fixation systems, its specific focus on the SpineVision systems in a multicentric observational context is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient implanted with Lumis®, Plus® or Ulis® posterior fixation system * Patient of 18 years old and more * Patient has provided signed informed consent or did not oppose to his/her data collection, per local regulation Exclusion Criteria: contra-indication * trauma (i.e., fracture or dislocation) * Known or suspected allergy or intolerance to the implanted material, mainly to metal (e.g., cobalt, chromium, nickel, etc.) * Any other medical or surgical condition likely to compromise the success of instrumented surgery, such as the presence of a malignant tumor or serious congenital abnormalities, raised erythrocyte sedimentation rate not explained by other diseases, high white blood cell count or a tendency to low white blood cell count * All cases not described in the indications * Localized infection of the operative site * All patients with insufficient tissue cover of the operative site * Local signs of inflammation * Fever or leukocytosis * Pathological obesity * Pregnancy * Mental illness * Rapidly evolving joint diseases, bone absorption, osteopenia and/or osteoporosis. Osteoporosis is a relative contraindication, as this medical condition can limit the expected correction gain and stability of mechanical fixation * All cases not requiring bone graft or bone fusion * When pedicular screws are used, absence or malformation of pedicles * All cases requiring a combination of different metals * All patients not agreeing to comply with post-operative instructions
Where it's running
-
DOSCEA Pôle Rachis
Bayonne, France Recruiting -
Clinique du dos Bordeaux-Terrefort
Bruges, France Recruiting -
Orthéo Neurochirurgie
Saint-Etienne, France Recruiting
Study contacts
- Principal investigator: Benjamin Pommier — Orthéo Neurochirurgie
- Study coordinator: Renaud Duchenes
- Email: r.duchenes@spinevision.com
- Phone: +33 6 86 16 61 91
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Autologous nucleus pulposus cell injection for degenerative lumbar disc disease.
This trial will try a single injection of your own nucleus pulposus cells into a degenerated lumbar disc to see if it reduces pain and is safe for people who are having or need a discectomy.
-
Evaluating the Hexanium TLIF System for treating degenerative disc disease
This study is testing a new system for back surgery to see if it safely helps people with degenerative disc disease feel less pain and improve their daily activities.
-
Evaluating the safety and effectiveness of INFUSE Bone Graft for spinal fusion
This study is testing how safe and effective the INFUSE Bone Graft is for spinal fusion surgery in patients in Korea over a year after their operation.
-
Creating a database of full body radiographs in healthy volunteers
This study is trying to create a database of full body x-rays from healthy people to help doctors understand normal bone structure and improve treatment for spine issues.
-
Gelified radiopaque ethanol for cervical disc herniation in routine care
This observational study looks at how patients with cervical disc herniation and chronic neck pain fare after treatment with Absolute Gel, used in standard clinical practice.
-
Bone marrow concentrate injection added to lumbar microdiscectomy
This trial tests whether adding a bone marrow aspirate concentrate injection during lumbar microdiscectomy helps adults recover better than surgery alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.